Trial intelligence / Profile preview

Topical 3% minoxidil + 0.25% finasteride vs 3% minoxidil for male androgenetic alopecia

TCTR20160910002Phase 3Completed

Sponsor
Division of Dermatology, Ramathibodi Hospital, Mahidol University
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of minoxidil, finasteride in androgenetic alopecia (AGA), sponsored by Division of Dermatology, Ramathibodi Hospital, Mahidol University. Started Jun 2015; status: completed.

02

Drugs

minoxidilfinasteride
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20160910002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160910002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call